Loading viewer...
investor_presentation
Format: PDF investor_presentation
This corporate presentation by RNXT outlines their late-clinical stage biopharmaceutical developments, focusing on pancreatic cancer therapies and future strategies.
Let us design a presentation that delivers.
LifeMD
NXP Semiconductors Investor Presentation — November 2018
19 Pages
NXP Semiconductors
Intrum Investor Presentation — March 2024
32 Pages
Intrum
Traeger Inc. Q2 2023 Investor Presentation
Traeger Inc.
NTT Global Data Centers Growth Strategy 2023 IR Day
37 Pages
NTT Corporation
Solvay Investor Presentation — February 2019
46 Pages
Solvay